PMVP

PMV Pharmaceuticals, Inc. - Common Stock (PMVP)

About PMV Pharmaceuticals, Inc. - Common Stock (PMVP)

PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.

Details

Daily high
$1.44
Daily low
$1.30
Price at open
--
52 Week High
$1.91
52 Week Low
$1.02
Market cap
104.2M
Dividend yield
-
Volume
21
Avg. volume
448,207
P/E ratio
-.98

PMV Pharmaceuticals, Inc. - Common Stock News

Details

Daily high
$1.44
Daily low
$1.30
Price at open
--
52 Week High
$1.91
52 Week Low
$1.02
Market cap
104.2M
Dividend yield
-
Volume
21
Avg. volume
448,207
P/E ratio
-.98